Publications of Sascha Young Kupke
All genres
Talk (25)
2018
Talk
Kupke, S. Y.Single-Cell analysis uncover a novel influenza A virus-derived defective interfering particle for antiviral therapyPresented at: Vaccine Technology VIIMont Tremblant, Canada, June 17, 2018.
2017
Talk
Rüdiger, D., Kupke, S. Y., Zmora, P., & Reichl, U.Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditionsPresented at: 3rd Workshop on Virus DynamicsHeidelberg, Germany, October 6, 2017.
2016
Talk
Kupke, S. Y., Heldt, S., Frensing, T., & Reichl, U.Single-Cell Analysis of Influenza A Virus-Infected CellsPresented at: 26th Annual Meeting of the Society for VirologyMünster, Germany, July 7, 2016.
Talk
Kupke, S. Y., Heldt, S., Frensing, T., & Reichl, U.Heterogeneity in Influenza A Virus Infection Unveiled by Single-Cell Analysis and Stochastic Mathemeatical ModelingPresented at: Single Cell Technologies 2016Frankfurt/Main, April 6, 2016.
Talk
Kupke, S. Y., Heldt, S., Frensing, T., & Reichl, U.Single-Cell Analysis of Influenza A Virus-Infected Cells for the Optimization of Cell Culture-Based Vaccine ProductionPresented at: Vaccine Technology VIAlbufeira, Portugal, June 12, 2016.
Poster (25)
2023
Poster
Dogra, T., Pelz, L., Rüdiger, D., , , , Marichal-Gallardo, P., Genzel, Y., , Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 32nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.
Poster
Dogra, T., Pelz, L., Rüdiger, D., , , , Marichal-Gallardo, P., Genzel, Y., , Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 8th European Congress of VirologyGdańsk (Poland), May 4, 2023.
Poster
Küchler, J., , Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of viral proteins during single-round replication of vaccine producer cell linesPresented at: 32nd Annual Meeting of the Society for Virology (GfV) Ulm (Germany), March 28, 2023.
Poster
Küchler, J., , Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell linesPresented at: 16th PEACe (Protein Expression in Animal Cells) ConferenceSitges (Spain), September 24, 2023.
Poster
Pelz, L., Dogra, T., , , Marichal-Gallardo, P., Genzel, Y., , Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.
Poster
Pelz, L., Dogra, T., , Marichal-Gallardo, P., , Genzel, Y., , Kupke, S. Y., & Reichl, U.A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo StudiesPresented at: Himmelfahrtstagung on Bioprocess Engineering 2023Weimar (Germany), May 15, 2023.
Poster
Pelz, L., Dogra, T., , Marichal-Gallardo, P., , Genzel, Y., , Kupke, S. Y., & Reichl, U.Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral EfficacyPresented at: 33rd Annual Meeting of the Society for Virology (GFV)Ulm (Germany), March 25, 2023.
Poster
Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviralPresented at: 8th European Congress of VirologyGdańsk (Poland), May 4, 2023.
Poster
Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7Presented at: 32nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.
Poster
Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U.Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviralPresented at: 17th Vaccine CongressGlasgow (Scotland), September 24, 2023.
2022
Poster
Dogra, T., Pelz, L., , Rüdiger, D., , , Kupke, S. Y., & Reichl, U.Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Poster
Hein, M., Chawla, A., , , , , Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Poster
Küchler, J., , , Genzel, Y., Kupke, S. Y., Benndorf, D., & Reichl, U.Absolute quantification of viral proteins during single-round replication of MDCK suspension cellsPresented at: Proteomic Forum 2022Leipzig (Germany), April 3, 2022.
Poster
Kupke, S. Y., , , , Marichal-Gallardo, P., , , , , & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: 31st Annual Meeting of the Society for Virologyonline, March 30, 2022.
Poster
Kupke, S. Y., Hein, M., , , Marichal-Gallardo, P., , , , , & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.